Medicare Enrolled
Dr. Julia Cogburn, M.D.
Hematology · Tampa, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cogburn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cogburn? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cogburn
Dr. Julia Cogburn is a hematology in Tampa, FL, with 18 years in practice. Based on federal Medicare data, Dr. Cogburn performed 91,460 Medicare services across 2,477 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cogburn received a total of $129,716 from 96 pharmaceutical and/or device companies across 1012 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cogburn is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 46% volume in FL$ $129,716 industry payments
Medicare Practice Summary
Medicare Utilization ↗91,460
Medicare services
Top 46% in FL for hematology
2,477
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,081 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 42,330 | $0 | $4 |
| Iron sucrose injection (Venofer) | 18,000 | $0 | $5 |
| Filgrastim injection (Zarxio) for white blood cells | 6,540 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia | 6,030 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 4,290 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 3,840 | $18 | $51 |
| Contrast dye for imaging (iodine-based) | 2,555 | $0 | $1 |
| Complete blood count (CBC) with differential | 1,321 | $8 | $29 |
| Blood draw (venipuncture) | 1,173 | $8 | $9 |
| Dexamethasone injection (steroid) | 887 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 630 | $1 | $28 |
| Drug injection, under skin or into muscle | 592 | $10 | $69 |
| Office visit, established patient (30-39 min) | 545 | $92 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 512 | $0 | $9 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 319 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 265 | $47 | $189 |
| Administration of chemotherapy into vein, 1 hour or less | 205 | $96 | $378 |
| Office visit, established patient (20-29 min) | 194 | $63 | $239 |
| Injection of additional new drug or substance into vein | 179 | $11 | $61 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 161 | $21 | $84 |
| Infusion into a vein for hydration, each additional hour | 100 | $10 | $42 |
| Administration of additional new drug or substance into vein, 1 hour or less | 77 | $48 | $178 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 74 | $17 | $59 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 67 | $3 | $11 |
| Infusion, normal saline solution , 1000 cc | 67 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 60 | $15 | $56 |
| Administration of chemotherapy into vein, each additional hour | 58 | $20 | $79 |
| Automated urinalysis | 56 | $2 | $8 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 43 | $401 | $680 |
| Injection, diphenhydramine hcl, up to 50 mg | 43 | $1 | $3 |
| Infusion into a vein for hydration, 31-60 minutes | 42 | $24 | $156 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 41 | $1,093 | $3,706 |
| Injection of drug or substance into vein | 37 | $28 | $156 |
| New patient office visit (30-44 min) | 27 | $82 | $298 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 27 | $1 | $7 |
| Ct scan of chest with contrast | 25 | $56 | $344 |
| CT scan of abdomen and pelvis with contrast | 18 | $145 | $550 |
| New patient office visit (45-59 min) | 18 | $131 | $453 |
| CT scan of chest, without contrast | 12 | $52 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
47.1% high complexity
49.1% medium
3.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$129,716
Total received (2018-2024)
Avg $18,531/year across 7 years
Top 3% in FL for hematology
96
Companies
1,012
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$109,121 (84.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,476 (14.2%)
Other
Charitable contributions, space rental, and other categories
$2,120 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,162
2023$3,019
2022$3,073
2021$1,355
2020$2,046
2019$2,863
2018$112,198
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SANOFI-AVENTIS U.S. LLC
$109,018
Novartis Pharmaceuticals Corporation
$3,573
Genentech USA, Inc.
$1,394
PFIZER INC.
$1,326
AstraZeneca Pharmaceuticals LP
$1,212
E.R. Squibb & Sons, L.L.C.
$931
Janssen Biotech, Inc.
$807
Eisai Inc.
$752
Celgene Corporation
$700
GENZYME CORPORATION
$518
Merck Sharp & Dohme LLC
$497
Daiichi Sankyo Inc.
$479
Merck Sharp & Dohme Corporation
$457
Seagen Inc.
$406
Lilly USA, LLC
$404
Incyte Corporation
$389
Amgen Inc.
$382
GlaxoSmithKline, LLC.
$372
Gilead Sciences, Inc.
$327
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Bayer HealthCare Pharmaceuticals Inc.
$241
ABBVIE INC.
$237
Takeda Pharmaceuticals U.S.A., Inc.
$211
Exelixis Inc.
$197
Boehringer Ingelheim Pharmaceuticals, Inc.
$197
Sirtex Medical Inc
$189
TESARO, Inc.
$187
Pharmacyclics LLC, an AbbVie Company
$177
Astellas Pharma US Inc
$161
NanoString Technologies, Inc.
$152
Mirati Therapeutics, Inc.
$134
Puma Biotechnology, Inc.
$133
BeiGene USA, Inc.
$129
ImmunoGen, Inc.
$128
TerSera Therapeutics LLC
$127
AMAG Pharmaceuticals, Inc.
$118
Pharmacosmos Therapeutics Inc.
$116
ARRAY BIOPHARMA INC
$115
Alexion Pharmaceuticals, Inc.
$109
Boston Scientific Corporation
$104
Bayer Healthcare Pharmaceuticals Inc.
$104
Deciphera Pharmaceuticals Inc.
$95
PUMA BIOTECHNOLOGY, INC.
$95
EMD Serono, Inc.
$92
Clovis Oncology, Inc.
$87
JAZZ PHARMACEUTICALS INC.
$80
EISAI INC.
$79
AVEO Pharmaceuticals, Inc.
$71
Taiho Oncology, Inc.
$70
Kite Pharma, Inc.
$69
CSL Behring
$66
MEDIVATION FIELD SOLUTIONS LLC
$65
Stemline Therapeutics Inc.
$63
CTI BioPharma Corp.
$60
Spectrum Pharmaceuticals Inc.
$57
SpringWorks Therapeutics, Inc.
$55
Seattle Genetics, Inc.
$54
AbbVie Inc.
$54
Myovant Sciences Inc.
$50
Array BioPharma Inc.
$49
Aadi Bioscience, Inc.
$47
Janssen Pharmaceuticals, Inc
$47
AbbVie, Inc.
$45
Myriad Genetic Laboratories, Inc.
$42
Regeneron Healthcare Solutions, Inc.
$40
Teva Pharmaceuticals USA, Inc.
$37
Pharmacyclics LLC, An AbbVie Company
$37
Agios Pharmaceuticals, Inc.
$37
ADC Therapeutics America, Inc.
$37
GE HealthCare
$36
Karyopharm Therapeutics Inc.
$35
TAIHO ONCOLOGY, INC.
$28
Blueprint Medicines Corporation
$26
SOBI, INC
$25
Telix Pharmaceuticals
$25
Foundation Medicine, Inc.
$23
Dendreon Pharmaceuticals LLC
$23
SERVIER PHARMACEUTICALS LLC
$23
Legend Biotech USA Inc.
$20
Sumitomo Pharma America, Inc.
$20
PharmaEssentia USA Corporation
$19
Genmab U.S., Inc.
$19
Sobi, Inc
$19
Acceleron Pharma, Inc.
$18
G1 Therapeutics, Inc.
$17
MorphoSys, US Inc.
$17
West Therapeutics Development, LLC
$17
Veracyte, Inc.
$16
Ipsen Biopharmaceuticals, Inc
$16
INSYS Therapeutics Inc
$14
Verastem, Inc.
$14
Acrotech Biopharma LLC
$14
Medtronic, Inc.
$14
Supernus Pharmaceuticals, Inc.
$13
Aurobindo Pharma USA, Inc.
$11
Rigel Pharmaceuticals, Inc.
$5
Top 3 companies account for 87.9% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Beleodaq · Braftovi · CABOMETYX · CALQUENCE · CARVYKTI · CEREZYME · CHANTIX · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · ELAHERE · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · EVENITY · Elahere · Enhertu · Epkinly · Erivedge · Erleada · FASLODEX · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · Folotyn · Fyarro · GAZYVA · GENERAL FEMALE SUI · GILOTRIF · Halaven · IBRANCE · IDHIFA · ILLUCCIX · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · INTELLIS · Idelvion · Imbruvica · Itovebi · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LEMTRADA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROVENGE · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · QELBREE · QINLOCK · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Stivarga · Subsys · TAFINLAR · TAGRISSO · TASIGNA · TAXOTERE · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xospata · Yescarta · ZEJULA · ZEPZELCA · ZIIHERA · Zevalin · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for hematology in FL.
Equivalent to $142 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
45
Per 100K population
3.0
County median income
$75,011
Nearest hospital
ADVENTHEALTH TAMPA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Cogburn is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 3%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Cogburn experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Cogburn performed 42,330 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cogburn receive payments from pharmaceutical companies?
Yes. Dr. Cogburn received a total of $129,716 from 96 companies across 1,012 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cogburn's costs compare to other hematologys in Tampa?
Dr. Cogburn's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cogburn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Tampa
Browse hematologys in Tampa ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology